Introduction
The importance of the APC tumor suppressor protein to normal cell physiology has been suggested by the association of APC gene mutations with familial and sporadic human colon carcinoma Joslyn et al., 1991; Nishisho, 1991) and, with intestinal tumors in mice (Luongo et al., 1994; Moser et al., 1990; Su et al., 1992) . The conventional form of APC including exons 1 ± 15, is expressed in most cells, but may encode a protein most critical in the differentiation of intestinal epithelial cells .
Recent work has shown that unique APC splice-forms are expressed in non-renewing cell populations suggesting that these APC protein isoforms may be involved in the physiology of cell cycle cessation (Santoro and Groden, 1997) . These alternative APC transcripts contain one or more of six additional exons of APC Horii et al., 1993; Sulekova et al., 1995; Thliveris et al., 1994) . Four of these exons are located 5' of exon 1 and at least two of these exons, BS and 0.3, contain in-frame translation initiation codons, obviating the need for the AUG in exon 1. Transcripts without exon 1, but that include either of these 5' exons, are prominent in neuronal cells (Santoro and Groden, unpublished observations) and in other tissues rich in non-dividing cells (Horii et al., 1993; Santoro and Groden, 1997) suggesting that APC isoforms may contribute to suppression of proliferation (Groden et al., 1995; Santoro and Groden, 1997) . In keeping with this idea, induction of dierentiation of myoblast cell cultures leads to an increase in the expression of APC transcripts that lack exon 1 (Santoro and Groden, 1997) . These data suggest that the expression of alternate APC protein isoforms or the switch in isoform types may play a role in cell cycle cessation or dierentiation (Santoro and Groden, 1997) .
The conventional form of the APC protein functions as a tumor suppressor, most likely through its interaction with, and down-regulation of, the signaling molecule b-catenin (Rubinfeld et al., 1993; Su et al., 1993b; Morin et al., 1997) . APC also interacts with the Drosophila Discs large (DLG) tumor suppressor (Matsumine et al., 1996) , and, in over-expression assays, with microtubules (Munemitsu et al., 1994; Smith et al., 1994) . APC protein has been localized to the advancing edge of the lamellipodia in ®broblasts suggesting a role in cell migration (Nathke et al., 1996) . The role of the conventional APC protein in these functions may depend upon homodimerization (Joslyn et al., 1993; Su et al., 1993a) , mediated through a series of heptad repeats in the amino terminal domain of APC; the ®rst heptad repeat of this dimerization domain is encoded by exon 1 Joslyn et al., 1993) . Proteins predicted by the sequence of RNA transcripts containing the novel 5' exons of APC do not contain the exon 1-encoded homodimerization domain, and are not as likely to form coiledcoil structures (Santoro and Groden, 1997) . These isoforms, therefore, would not be expected to interact with exon 1-encoded APC isoforms. Although exon-1-encoded sequences may play a critical role in the function of the conventional APC protein isoform, the function of the`exon 1-less' isoforms in non-dividing cells clearly would not rely on this domain.
One of the 5' exons that appeared likely to encode protein because it contained an initiating AUG in a favorable context (Santoro and Groden, 1997) , was designated BS for brain-speci®c (Horii et al., 1993) . Sequencing of RNA transcripts containing the BS exon, now known not to be restricted to brain, indicated that the BS exon was spliced to exon 2, creating a novel APC open reading frame (Santoro and Groden, 1997) . The distribution and nature of protein isoforms encoded by this transcript would be of interest as the unique amino-terminus may specify dierences in protein structure, protein-protein interactions and, therefore, function relative to the conventional form of APC protein. Additionally, the appearance of these APC splice-forms in post-mitotic tissue suggest additional or novel functional roles in the control of growth and/or dierentiation.
Anity-puri®ed, polyclonal antibodies speci®c for the human BS sequence were generated to determine if the APC BS exon is utilized for the synthesis of alternate APC isoforms and to examine initially the potential roles played by BS ± APC proteins. We examined neural tissue because APC transcripts that lack exon 1 are enriched in brain, heart, and skeletal muscle relative to other tissues (Santoro and Groden, 1997) and because overall levels of APC are highest in brain (Bhat et al., 1994) . Our studies show that BS is indeed a coding exon and that several BS isoforms can be identi®ed in neural tissue. The BS ± APC isoforms do not interact with exon 1-containing APC proteins, but were found to associate with b-catenin.
Results

BS ± APC protein isoforms are found in protein lysates from brain
To determine if BS ± APC transcripts directed protein synthesis in vivo, protein lysates from human cerebrum were immunoblotted with the BS-speci®c antibody. A large protein of *300 kD predicted by the BS-2-15 APC transcript, and three other prominent species of 290 kD, 200 kD, and 150 kD were identi®ed ( Figure 1a , lane 1).
These proteins also were identi®ed in brain extracts with the C-20 antibody that is speci®c for the terminal 20 amino acids encoded by APC exon 15 (lane 2). Protein extracts of fragments of cerebrum from another patient, and from a baboon, showed an identical labeling pattern with BS antibody (data not shown), indicating that these proteins are common to primates.
To establish a readily renewable source of high quality protein, we looked for BS proteins in rodent neural tissues. Immunoblots of rat cerebral and cerebellar proteins also showed a prominent *300 kD reactive protein (Figure 1b , lanes 1 and 2, respectively). Consistent with the ®ndings using human and baboon tissues, in addition to the 300 kD species, proteins migrating similarly to the 290 kD, 200 kD, and 150 kD species also were observed. Western blots of rat tissues, in which gels were prepared at higher acrylamide concentration to retain low molecular weight species, allowed detection of two additional species of 90 kD and 40 kD (data not shown).
To conclude that the BS proteins were APC isoforms, it was necessary to show that they contained APC epitopes outside of the BS-encoded sequence. We focused on the four prominent high molecular weight proteins for further study. It was of particular interest to determine which APC epitopes might be found in the 290 kD, 200 kD and 150 kD proteins as each would necessarily have been derived by as yet uncharacterized alternative splicing of APC. BSimmunoprecipitates of rat cerebral protein lysates were blotted and labeled with three APC antibodies that recognize exon 1-, exon 2-, or exon 15-encoded protein epitopes.
Initial experiments, in which protein was immunoprecipitated from rat cerebral homogenates by BS antibody and then labeled with BS antibody on immunoblots, revealed that all four high molecular weight species seen in the initial examination of brain extracts were recovered by immunoprecipitation ( 
BS ± APC protein does not interact with conventional APC, but does interact with b-catenin
The presence of BS ± APC protein isoforms in dierentiated cell types suggests novel functions for these proteins. To begin to study the possible roles that BS ± APC proteins perform, we sought to determine whether BS ± APC protein isoforms interacted with other APC isoforms and/or with other known protein partners of APC. Initially, we sought to determine whether the protein pro®le of a BS immunoprecipitate was simple or complex. BS ± APC immunoprecipitates from adult rat cerebrum that were electrophoresed, blotted, and stained by Amido black, showed a number of bands ( Figure 3a , lane 1). A number of these bands also were found in immunoprecipitates of the same rat cerebrum extract with the C-20 antibody ( Figure 3a , lane 2). This comparison revealed protein bands in the BS-immunoprecipitates that were not evident in the C-20 immunoprecipitates, suggesting that there are a number of proteins that interact with BS ± APC and that are distinct from those that interact with the conventional form of APC. Recent studies have suggested the importance of the interaction between conventional 1 ± 15 APC protein and the b-catenin protein (Morin et al., 1997) . To determine if the BS ± APC isoforms also interact with b-catenin, rat cerebrum BS-immunoprecipitates were probed with a b-catenin-speci®c monoclonal antibody. We predicted that at least the full-length BS ± APC protein would interact with b-catenin because its size suggested that the b-catenin binding and downregulation domains would be present (Rubinfeld et al., 1993; Su et al., 1993b) . The BS ± APC immunoprecipitations included at least as much b-catenin protein (Figure 3b , lane 1) as APC immunoprecipitations with the Ab-5 antibody (Figure 3b, lane 2) . These ®ndings suggest that, similar to conventional APC, one or more of the BS ± APC protein isoforms associate with bcatenin.
Finally, to determine whether conventional APC interacted with any of the BS ± APC isoforms, BSimmunoprecipitates were labeled with antibody to an exon 1-encoded epitope (N-15). This antibody recognizes an epitope within the ®rst heptad repeat of APC that is necessary for homodimerization. No species that reacted with the N-15 antibody was present in the BSimmunoprecipitate (Figure 3c , lane 1), con®rming that BS ± APC proteins lack exon 1-encoded epitopes, as predicted by the RNA analyses. The identical extract, when incubated with the APC exon 15 antibody for immunoprecipitation and then labeled with the N-15 antibody, however, showed that APC proteins with this epitope were present in the extract (Figure 3c, lane 2) . This result suggests that BS ± APC proteins do not interact with the conventional form of APC. Thus, BS ± APC isoforms can share potential protein partners with conventional APC, but, perhaps most important, dimerization with exon 1-encoded isoforms is not likely to be essential to BS ± APC function.
Discussion
The role of conventional APC in normal gut epithelium is slowly being elucidated. Its role in the nervous system, however, has not been extensively studied in spite of the fact that APC is more highly expressed in brain than in any other tissue (Bhat et al., 1994) . In limited studies of APC in brain thus far, using either of two probes to regions of APC downstream of exon 2, Bhat and colleagues (1994) showed by in situ hybridization that APC RNA is expressed throughout the rat brain during development and remains abundant in the olfactory bulb, hippocampus and cerebellum in the adult. In embryonic brain, APC mRNA was particularly abundant in cortical, cerebellar, and retinal layers containing newly formed, post-mitotic neurons, suggesting that APC may contribute to suppressing neuronal proliferation (Bhat et al., 1994) . The role of APC isoforms in brain may be signi®cant in that germline mutation of APC is associated with central nervous system tumors in some families (Groden, 1995; Mori et al., 1994; Hamilton et al., 1995) . The in situ probes used by Bhat and colleagues (1994) , however, did not allow determination of the temporal expression and distribution of transcripts likely to encode BS proteins, i.e., transcripts in which BS is spliced to exon 2 vs conventional exon 1-containing APC splice-forms. Adult rat brain extracts contain BS ± APC as well as non-BS ± APC proteins ( Figure 2, this manuscript) . Thus, in terms of understanding BS ± APC protein function, it would be useful to determine with which parameter of neural differentiation BS ± APC protein expression is most closely associated.
The *300 kD BS ± APC protein, identi®ed in human, baboon and rat neural tissues was predicted from reverse-transcription PCR (Santoro and Groden, 1997) . We also identi®ed BS ± APC isoforms of 290, 200 and 150 kD in neural tissues as well as BSantibody reactive proteins of 90 and 40 kD. There have been several reports in the literature of *150 kD APC proteins (Kraus et al., 1996; Miyashiro et al., 1995) , although no cDNA has been reported yet that would be predicted to encode a protein of this size. The 150 kD isoform may be more stable than the larger isoforms because brain tissue samples that lost reactivity to the larger bands, presumably due to sample degradation, uniformly retain an intact 150 kD band (R. Pyles, unpublished data). The 150 kD protein contains the extreme animo-and carboxyl-terminal epitopes, as well as epitopes encoded by exon 2, and therefore, is not likely to be a degradation product of the 300 kD BS ± APC. More likely, the 150 kD protein is encoded by a novel, internal splice-variant of the APC gene. It will be important to determine what protein domains are missing in the 150 kD isoform and the other nonfull-length BS ± APC isoforms relative to full-length APC. At the least, all BS ± APC isoforms have two changes relative to conventional APC that could be functionally signi®cant; they lack an a-helical-rich protein interaction domain, and contain a novel amino-terminus.
We have shown that the BS ± APC isoforms do not interact with APC isoforms that contain exon 1-encoded sequence (Figure 3 ), or the homodimerization domain Joslyn et al., 1993) . It is not clear why cells require such a diversity of APC isoforms, but the presence of such isoforms with selected domains may make these dierent isoforms functional`specialists'. Alternatively, splicing events could generate new protein motifs that specify new functions. Clearly, determining the RNA splicing events that give rise to the dierent isoforms is key to understanding these possible roles. Immunoprecipitates from rat cerebrum using BS antibody (lane 1, BS) or Ab-5 (lane 2, Ab-5) were labeled with a b-catenin monoclonal antibody to determine if BS ± APC protein interacted with b-catenin. BS ± APC protein isoforms lack exon 1-encoded sequences involved in homodimerization (Joslyn et al., 1993; Su et al., 1993a) . Therefore, we determined whether BS ± APC interacted with the exon 1-15-encoded APC. 
Materials and methods
Bacterial expression constructs
The BS exon of APC was ampli®ed by the polymerase chain reaction using cDNA from human cerebrum and the primer pair 5'CCG CCA TGG GAT CCT CTA AGG AAA CGG GTA GAG GAC-3' and 5'-CCG CAA GCT TGA ATT TCA TCC CCA GTA GCT CTT TCC AC-3'. The primers included novel 5' NcoI and BamHI restriction endonuclease sites and novel 3' HindIII and EcoRI sites to aid in cloning. The BS exon was cloned directionally, using the NcoI and HindIII sites, into both pGEX-KG (Guan and Dixon, 1991) , that directs the expression of a BSglutathione-S-transferase (BSGST) fusion protein, and the pPROEX-1 vector (GIBCO/BRL), that expresses a BS-6-histidine (BS6HIS) tagged fusion protein. Each clone was sequenced completely, prior to protein production, by the University of Cincinnati DNA Core using an automated ABI 373A sequencer. BSGST fusion protein was puri®ed using glutathioneagarose (Sigma) and standard protocols (Guan and Dixon, 1991; Pharmacia) . The pPROEX-1 fusion protein was puri®ed on nickel-bound resin (GIBCO/BRL) using the manufacturer's recommended method. The purity of the fusion protein preparation was veri®ed by SDS ± PAGE prior to rabbit immunizations or anity puri®cation.
BS antibody production/immunizations
Female New Zealand white rabbits were purchased from Myrtle's Rabbitry (Thompson Station, TN) and housed in AAALAC-approved animal quarters. Screening of preimmune sera facilitated rabbit selection. Each rabbit was immunized following the protocol recommended by H. Alexander (University of Missouri; Tainer et al., 1984) . Brie¯y, the rabbit was injected subcutaneously with 1 mg of puri®ed BSGST antigen emulsi®ed in complete Freund's adjuvant. The rabbits were boosted 14 days later with 0.75 mg of puri®ed antigen emulsi®ed in incomplete Freund's adjuvant. An intraperitoneal injection of 0.5 mg of antigen was delivered in alum (A1(OH) 3 ) adjuvant 21 days after the initial injection. Additional intraperitoneal injections of antigen in alum were given monthly. Immuneserum was collected via the ear vein 10 days after each antigen/alum boost. High titers of BS-speci®c antibody were detected following the second antigen/alum injection.
Antibody anity-puri®cation BS-speci®c antibodies were isolated from serum by anity for the BS6HIS fusion protein linked to AGel-10 (BioRad). Anity-puri®cation was performed as suggested by the manufacturer and standard protocols (Harlow and Lane, 1988) . Brie¯y, 5 mg of puri®ed BS6HIS protein was mixed with 3 ml of AGel-10 and agitated for 24 h at 48C. The protein-bound gel was collected by centrifugation and then cross-linked to the gel by exposure to 0.1 M glycine, pH 2.5. Following neutralization with 0.1 M ethanolamine, pH 8.0, the resin was washed with 0.1 M MOPS, pH 7.0, loaded onto a mini column (Bio-Rad) and allowed to pack by gravity. The column was stored with fresh MOPS at 48C until used.
To collect BS-speci®c antibodies, BS-reactive serum was loaded onto the freshly drained column. The¯ow-through was collected and reloaded twice more. Non-speci®cally bound antibodies were rinsed away with 10 mM TrisCl, pH 7.5. BS-speci®c antibodies were eluted with 100 mM glycine, pH 2.5 into aliquots of 1 M Tris, pH 8.0. Anity-puri®ed antibody was tested for its speci®city by immunoblotting of bacterial lysates that expressed BSGST, GST alone, or an unrelated APC-GST protein. Whole serum reacted with a number of bands in the bacterial lysate, but the puri®ed antibody reacted only with BSGST (data not shown).
Additional antibodies
A monoclonal antibody speci®c for b-catenin was purchased from Transduction Labs (Lexington, KY). Polyclonal antibodies speci®c for the ®rst 15 amino acids of APC exon 1 (N-15) or the last 20 amino acids of APC exon 15 (C-20) were purchased from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA). Monoclonal antibody that detects epitopes encoded by APC exon 2 (Ab-5) was purchased from Oncogene Science, Inc. (Cambridge, MA).
Immunoprecipitations and immunoblotting
Tissues for protein preparation were harvested from Fischer rats and outbred Swiss Webster mice (Charles River). Baboon neural tissue was provided by the University of Cincinnati Cardiology Department. All animals were housed in AAALAC-approved animal facilities at the University of Cincinnati. Human brain tissue was provided by Dr Ronald Warnick from the Department of Neurosurgery at the University of Cincinnati.
Tissue extracts for immunoblotting and immunoprecipitation were prepared using protocols from Oncogene Science, Inc. Tissues either were used directly or immediately frozen and stored in liquid nitrogen for later protein preparation. For each preparation, *100 mg of tissue was minced and homogenized in 1 ml of freshly prepared lysis buer (50 mM Tris, 100 mM NaCl, 0.5% NP-40, 1 mM phenylmethyl sulfonyl¯uoride, 5 mM EDTA, pH 7.5) on ice. The lysate was incubated at 48C with agitation for an additional 30 min and then clari®ed by centrifugation (10 000 g for 30 min at 48C). The clari®ed supernatant was transferred to fresh tubes, mixed 1 : 1 with Laemmli sample buer and boiled for 10 min prior to SDS ± PAGE.
Supernatants for immunoprecipitations were prepared as described above and then pre-cleared with Pansorbin (Calbiochem) and mouse or rabbit IgG by mixing for 30 min at 48C. Following centrifugation, the pre-cleared supernatant was mixed with 1 ± 10 mg of antibody and incubated for an additional 30 min at 48C. Protein Asepharose (Sigma) was added and the mixture was incubated an additional 30 min. Immune-complexes were collected by centrifugation and freed of non-speci®c proteins by four washes with lysis buer. The ®nal pellet was resuspended in Laemmli buer, boiled for 10 min and then electrophoresed.
SDS ± PAGE and immunoblotting
Due to the large size of the APC protein, 5% polyacrylamide gels containing 25% glycerol were employed for immunoblots (Carraro and Catani, 1983) . Proteins were transferred from gels at a constant 100 V for 60 min at 48C onto Immobilon-P transfer membrane (Fisher). The immunoblots were processed using standard methods (Harlow and Lane, 1988) and developed using the ECL chemiluminescent kit (Amersham). The labeling antibodies were diluted 100-fold in 5% non-fat dry milk in Tris-saline (TS) prior to immunoblotting. Kodak-AR ®lm was used for visualization of reactive protein bands.
